Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
4,311
Total Claims
$3.1M
Drug Cost
377
Beneficiaries
$8,117
Cost/Patient
Risk Score Breakdown 22/100
Score components are additive. Read full methodology
Peer Comparison vs. 13,194 Neurology providers
-41%
Opioid rate vs peers
0.8% vs 1.3% avg
+101%
Cost per patient vs peers
$8,117 vs $4,034 avg
+96%
Brand preference vs peers
18.4% vs 9.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.8%
Opioid Rate
33
Opioid Claims
$965
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 794 claims · $2.6M
Generic: 3,517 claims · $414K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Pimavanserin Tartrate | 270 | $1.5M |
| Amantadine Hcl | 147 | $484K |
| Carbidopa/Levodopa | 235 | $431K |
| Droxidopa | 43 | $220K |
| Onabotulinumtoxina | 36 | $70K |
| Carbidopa/Levodopa | 731 | $57K |
| Carbidopa/Levodopa | 551 | $43K |
| Opicapone | 17 | $23K |
| Atogepant | 12 | $23K |
| Rasagiline Mesylate | 66 | $21K |
| Rivastigmine Tartrate | 87 | $8,253 |
| Amantadine Hcl | 87 | $6,584 |
| Ropinirole Hcl | 153 | $5,507 |
| Ropinirole Hcl | 19 | $4,585 |
| Selegiline Hcl | 30 | $4,176 |
Prescribing Profile
43
Unique Drugs
22.0
Anomaly Score
Patient Profile
74
Avg Age
49%
Female
1.47
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About